JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Price:
2.55 HKD
3.66%
Updated:
May 20, 2024
JW (Cayman) Therapeutics Co Ltd
Cash Interest Paid
|
JW (Cayman) Therapeutics Co Ltd
Cash Interest Paid Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Cash Interest Paid
¥12.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash Interest Paid
¥127.6m
|
CAGR 3-Years
41%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Cash Interest Paid?
Cash Interest Paid
12.4m
CNY
12.4m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Cash Interest Paid amounts to 12.4m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
34%
34%
Over the last year, the Cash Interest Paid growth was 83%. The average annual Cash Interest Paid growth rates for JW (Cayman) Therapeutics Co Ltd have been 33% over the past three years , 34% over the past five years .
You don't have any saved screeners yet
